Allovir

ALVR

Q4 FY2024 Earnings

Financial report interval: 2024.10.01 - 2024.12.31

Overview: Allovir(ALVR) the EBIT is -19.52 M (+55.46%);the EPS is -3.64 (+69.76%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.02B55.46%
----
----
EPS
-3.63669.76%
----
----

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf